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Summary
Mutations in IKBKAP, encoding a subunit of Elonga-
tor, cause familial dysautonomia (FD), a severe neuro-
developmental disease with complex clinical charac-
teristics. Elongator was previously linked not only
with transcriptional elongation and histone acetyla-
tion but also with other cellular processes. Here, we
used RNA interference (RNAi) and fibroblasts from
FD patients to identify Elongator target genes and
study the role of Elongator in transcription. Strikingly,
whereas Elongator is recruited to both target and non-
target genes, only target genes display histone H3 hy-
poacetylation and progressively lower RNAPII density
through the coding region in FD cells. Interestingly,
several target genes encode proteins implicated in
cell motility. Indeed, characterization of IKAP/hELP1
RNAi cells, FD fibroblasts, and neuronal cell-derived
cells uncovered defects in this cellular function upon
Elongator depletion. These results indicate that de-
fects in Elongator function affect transcriptional elon-
gation of several genes and that the ensuing cell motil-
ity deficienciesmay underlie the neuropathology of FD
patients.
Introduction
FD is an autosomal recessive disease, ranging among
the most frequent hereditary sensory and autonomic
*Correspondence: j.svejstrup@cancer.org.uk (J.Q.S.); alain.chariot@
ulg.ac.be (A.C.)neuropathies (Slaugenhaupt and Gusella, 2002; Axelrod,
2004). Affected individuals are born with the disease and
abnormally low numbers of neurons in the autonomic
and sensory nervous systems, which initially triggered
a search for the disease gene among candidates in-
volved in neuronal differentiation and cell migration. FD
turned out to be caused by mutations in a splice site of
the IKBKAP gene, which causes tissue-specific exon
skipping, and expression of a truncated mRNA transcript
(Anderson et al., 2001; Slaugenhaupt et al., 2001). The
predicted, shorter form of the encoded IKAP protein
cannot be detected in patients (Slaugenhaupt et al.,
2001), because the truncated transcript is degraded by
the nonsense-mediated decay pathway (Slaugenhaupt
et al., 2004). FD mutations are incompletely penetrant,
so that normal IKAP protein is still synthesized in pa-
tients, albeit at lower levels, depending on cell type. In-
deed, IKAP levels arevery low inbrain tissues from FD pa-
tients (Slaugenhaupt et al., 2001; Cuajungco et al., 2003).
IKAP was initially described as a scaffold protein of the
IKK complex involved in NF-kB activation (Cohen et al.,
1998). However, a role for IKAP protein in this pathway
was later disproved (Krappmann et al., 2000). The IKAP
protein and its yeast homolog, Elp1, are components
of the highly conserved transcription elongation factor
complex Elongator (Hawkes et al., 2002; Kim et al.,
2002). Elongator was originally identified as a component
of a hyperphosphorylated RNA polymerase II (RNAPII)
holoenzyme isolated from budding yeast chromatin
(Otero et al., 1999). Significantly, another subunit of Elon-
gator, Elp3, harbors motifs found in the GNAT family of
histone acetyltransferases (HATs) (Wittschieben et al.,
1999). Both yeast and human Elongator have HAT activ-
ity in vitro, primarily directed toward histone H3 (Winkler
et al., 2002; Hawkes et al., 2002; Kim et al., 2002), and
yeast elp3 mutation results in decreased histone H3
acetylation levels in chromatin in vivo (Winkler et al.,
2002; Kristjuhan et al., 2002). In agreement with a role
in transcript elongation, Elongator is associated with
the nascent RNA emanating from elongating RNAPII
along the coding region of several yeast genes (Gilbert
et al., 2004), and chromatin immunoprecipitation (ChIP)
experiments have also demonstrated an association
of Elongator with genes in human cells (Metivier et al.,
2003; Kouskouti and Talianidis, 2005).
Surprisingly, a substantial fraction of Elongator is cy-
toplasmic (Hawkes et al., 2002; Holmberg et al., 2002;
Kim et al., 2002), suggesting that the complex performs
additional distinct functions in the cell (Gilbert et al.,
2004). For example, a role as a scaffold protein involved
in cytoplasmic JNK activation in response to extracellu-
lar stress has been proposed for the IKAP/hELP1 pro-
tein in mammalian cells (Holmberg et al., 2002). In yeast,
genetic data have implicated the Elongator complex in
processes as diverse as exocytosis and tRNA modifica-
tion (Rahl et al., 2005; Huang et al., 2005). The relation-
ship between Elongator’s role in transcription and these
other processes remains poorly understood.
To gain further insight into the role played by Elonga-
tor in transcription in human cells, and concomitantly
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used an RNAi strategy to deplete the IKAP/hELP1 sub-
unit of Elongator. Using DNA microarray analysis, we
then identified Elongator-dependent genes. Here, we
show that Elongator depletion affects the expression
of a number of genes, with correlating effects on histone
H3 acetylation and transcriptional elongation. Several of
the affected genes are implicated in cell motility, and
cells with decreased IKAP/hElp1 levels indeed display
defects in this cellular function. These data open the in-
triguing possibility that impaired cell motility/migration
in the nervous system underlies the neuropathology of
FD patients.
Results
IKAP/Elongator Regulates the Expression
of Genes Involved in Cell Migration
In order to investigate the biological role of IKAP/Elonga-
tor in human cells, HeLa cells were infected with a lentivi-
rus delivering small interfering RNAs targeting either
the IKAP/hELP1 transcript or GFP as a negative control.
Because IKAP/hELP1 had previously been implicated in
assembling stress-induced and cytoplasmic kinase
complexes (Cohen et al., 1998; Holmberg et al., 2002),
we first addressed the potential role of IKAP/hELP1 in
these pathways (Figure S1 available in the Supplemental
Data with this article online). A number of different assays
investigating the involvement of IKAP/hELP1 in Erk, p38,
and JNK activation, as well as in the IKK-mediated NF-kB
activation pathway, failed to uncover significant effects
(Figure S1). Similarly, no effect on cytoplasmic kinase
signaling was uncovered in fibroblasts derived from FD
patients (Figure S1). Taken together, our data indicate
that, in these cells, stress-induced MAPK and NF-kB
signaling pathways can proceed through IKAP/hELP1-
independent mechanisms.
Because there is substantial evidence linking IKAP/
hELP1 to transcriptional elongation in the context of
the Elongator complex, we next sought to identify genes
whose normal expression requires IKAP/hELP1. HeLa
cells were transfected with RNAi oligos that target either
the IKAP/hELP1 transcript or the GFP transcript as
a negative control. Decreased IKAP/hELP1 mRNA and
protein expression in response to IKAP/hELP1 RNAi
treatment of HeLa cells was confirmed (Figures 1A and
1B, respectively). Total mRNA was then extracted from
the RNAi-treated cells and subjected to microarray anal-
ysis. The expression of about 100 genes was signifi-
cantly downregulated as a result of IKAP/hELP1 RNAi
(Figure 1C and Figure S2A), whereas some 15 genes
were upregulated (Figure S2B). The expression of
TNFa and NF-kB-regulated target genes such as IL-1b
and IkBa was not altered in TNFa-stimulated IKAP/
hELP1 RNAi cells (P.C. and A.C., unpublished data),
further supporting the conclusion that these signaling
pathways are insensitive to IKAP/hELP1 levels.
Interestingly, a significant proportion (15 out ofw100)
of the downregulated genes encode proteins regulating
cell motility, such as those coding for the integrin recep-
tor CD61, the ligand tenascin-C, and the actin cytoskele-
ton modulators gelsolin, paxillin, and caveolin-1 (Fig-
ure 1C). Genes coding for proteins involved in cell
proliferation, such as thymidylate synthetase and thecyclin-dependent kinase inhibitor p57, kip2, as well as
various genes coding for proteins playing critical roles
in cellular processes such as autophagy (beclin-1), me-
tabolism (transglutaminase 2), and DNA repair (hMSH2)
were downregulated as well (Figure 1C and Figure S2A).
We examined the validity of our microarray results by
performing quantitative real-time PCR with total RNA
extracted from untransfected cells or from cells trans-
fected with RNAi. Hereby, the decreased expression of
several target genes in IKAP/hELP1-depleted cells was
confirmed (Figure 2A). Moreover, reduced expression
of paxillin and calreticulin was also confirmed at the pro-
tein level in these cells (Figure 2B).
To investigate the physiological importance and pos-
sible disease relevance of the observed effect of IKAP/
hELP1 RNAi on transcription, total RNA was also ex-
tracted from FD patient-derived fibroblasts (where IKAP/
hELP1 levels are reduced through the IKBKAP splice site
mutation) and subjected to quantitative real-time PCR
analysis. In support of the results obtained with RNAi-
transfected cells, decreased expression of gelsolin, pax-
illin, laminin b3, and beclin-1, but not a-tubulin, was also
observed in FD fibroblasts (Figure 2C). Interestingly,
Figure 1. Identification of Genes Regulated by IKAP/Elongator
(A and B) Decreased IKAP mRNA (A) and protein (B) expression in
HeLa cells transfected with IKAP/hELP1 RNAi (lane 2), as compared
to untransfected cells (lane 1) or cells transfected with a GFP control
RNAi (lane 3), as judged by real-time PCR (A) or by anti-IKAP/hELP1
Western blot analysis (B). An anti-a-tubulin Western blot is shown in
(B) for normalization purposes.
(C) Identification of IKAP/hELP1-dependent genes. Total RNA was
isolated from HeLa cells transfected with either IKAP/hELP1 or
GFP RNAi, as well as from untransfected control cells. The RNA
was then subjected to microarray analysis. Examples of affected
genes are shown. The full list of affected genes is shown in Figure S2.
Error bars in (A) denote standard deviation.
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pression of Genes Involved in Cell Migration
(A) Decreased expression of a subset of
genes involved in cell migration in IKAP/
hELP1 RNAi cells. RNA was extracted from
untransfected HeLa cells (2) or HeLa cells
transfected with IKAP/hELP1 RNAi (IKAP) or
GFP RNAi (GFP), respectively, and gene ex-
pression was measured by quantitative real-
time RT-PCR. Expression in the untrans-
fected cells was set to 100. b-glucuronidase
(GUS) expression is shown as a control.
(B) Levels of paxillin and calreticulin proteins
in IKAP/hELP1 RNAi cells examined by West-
ern blot analysis. An a-tubulin Western blot is
shown as loading control.
(C) Decreased expression of a subset of
genes in FD fibroblasts (FD) versus wild-type
cells (wt) measured by quantitative real-time
RT-PCR. a-tubulin expression is shown as
a control. Expression in the wt cells was set
to 100.
(D) Rac expression in FD fibroblasts exam-
ined by Western blot analysis, probing with
the antibodies is indicated below the panels.
Error bars in (A) and (C) denote standard devi-
ation.some cell type specificity in the expression patterns
might occur because the expression of genes such as te-
nascin-C and MMP2 did not appear to be significantly al-
tered in FD fibroblasts (data not shown).
Decreased gelsolin expression in fibroblasts is known
tobeassociated withenhanced expression of the GTPase
Rac in compensation for the reduced cell motility of
these cells (Azuma et al., 1998). We indeed observed
increased Rac expression in FD fibroblasts compared
to control cells, whereas IKAP/hELP1 expression as
expected was decreased (Figure 2D, compare top two
panels).
Taken together, these results demonstrate that low
IKAP/hELP1 levels, resulting from either RNAi or from
the splicing mutation in FD cells, similarly affect the ex-
pression of several genes.
Impaired IKAP/hELP1 Expression
Alters Cell Migration
The gene expression data suggest that IKAP/hELP1 de-
pletion leads to lower levels of expression of numerous
genes, including several implicated in cell motility. Be-
cause normal cell motility is of crucial importance for
the developing nervous system (reviewed by da Silva
and Dotti [2002] and Dent and Gertler [2003]) and there-
fore of obvious relevance to FD, we characterized the
potential role of IKAP/hELP1 in cell motility at the cellular
level. IKAP/hELP1 shRNA and control shRNA cells were
first compared in a wound-healing assay. This assay
measures the ability of cells to migrate (cell proliferationbeing inhibited by mitomycin C) and fill the gap left by
physical disruption of cell monolayers (West et al.,
2001). Significantly, a delay in complete ‘‘wound closure’’
was observed in IKAP/hELP1 shRNA HeLa cells com-
pared to control cells. Whereas complete closure was
observed after 22 hr with the control cells, gaps in the
cell monolayers remained open in the IKAP/hELP1
shRNA cells (Figure 3A). Next, the ability of IKAP/
hELP1 shRNA cells to migrate in response to a serum
gradient was investigated by using Boyden chambers
(Riedy et al., 1999). Again, a clear defect in cell migration
was observed in IKAP/hELP1 shRNA HeLa cells (Fig-
ure 3B).
To further correlate the observed migration defects
with decreased IKAP/hELP1 expression and FD, wound-
healing assays were also performed with two distinct cell
lines from FD patients and control fibroblasts. Although
significant closure of the gaps in cell monolayers had oc-
curred after 14 hr in control fibroblasts, a clear defect in
gap closure by cell migration was observed in FD fibro-
blasts (Figure 3C).
Cell motility of fibroblasts has been extensively stud-
ied by collagen gel contraction assays, in which contrac-
tion occurs as a consequence of motile activity of cells
migrating through the matrix (Grinnell, 1994). We took
advantage of such experiments to further characterize
the cell motility defects in FD fibroblasts. Experiments
over a 10 day period showed that control fibroblasts
were significantly more potent than FD cells in contract-
ing collagen gels (Figure 3D), indicating that the ability of
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(A) Wound-healing assays performed with shRNA GFP or shRNA IKAP/hELP1 in HeLa cells (left and right, respectively). Pictures were taken at
the indicated times after wounding.
(B) Chemotaxis assays using a Boyden chamber carried out with shRNA GFP (large, open squares; Ctr) or shRNA IKAP HeLa (small, filled
squares; IKAP). Cells migrating to the lower membrane were counted. The figure shows the total number of migrating cells after the indicated
times. Three independent experiments were performed in triplicate, with similar results. The average, with standard deviation, of one such ex-
periment is shown.
(C) Wound-healing assays performed with wt or FD fibroblasts (left and right, respectively). Pictures were taken at the indicated time points after
wounding.
(D) Contraction of free-floating collagen lattices seeded with either wt or FD fibroblasts. Photographs taken during the course of a representative
experiment are shown on the left. A graphic representation of the experiment is shown on the right, with standard deviations indicated.
(E) Top, an anti-IKAP/hELP1 Western blot performed on cell lysates derived from shRNA GFP or shRNA IKAP/hELP1 SK-N-BE cells. Bottom, as
in (A) but using SK-N-BE cells.
(F) As in (B) but using SK-N-BE cells. Two independent experiments were performed in triplicate, with similar results. The average, with standard
deviation, of one such experiment is shown.the mutant cells to spread and elongate is significantly
perturbed. Similar results were obtained with cells in
which IKAP/hELP1 levels had been depleted by RNAi(P.C. and A.C., unpublished data). Therefore, decreased
IKAP/hELP1 expression correlates with a cell migration
defect in fibroblasts from FD patients as well.
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rons in the autonomic and sensory nervous systems, it
was of great interest to also assess cell migration in an
IKAP/hELP1-depleted neuronal cell-derived cell line.
To do so, we infected neuroblastoma-derived SK-N-BE
cells with the IKAP/hELP1 or GFP shRNA constructs.
The infected cells were then plated on fibronectin-
coated plates and subjected to wound-healing assays.
Significantly, a clear delay in wound closure was ob-
served in SK-N-BE cells expressing lower amounts of
IKAP/hELP1 (Figure 3E). A similar cell migration delay
was also obtained with IKAP/hELP1-depleted glioblas-
toma-derived U373 cells (data not shown). Moreover,
cell motility defects as judged by chemotaxis assay us-
ing Boyden chambers were observed in SK-N-BE and in
U373 Elongator-depleted cells as well (Figure 3F and
data not shown). Taken together, these functional as-
says strongly suggest that the transcription defects in
IKAP/hELP1 cells have cell functional consequences
so that a number of different cell types with lower levels
of IKAP/hELP1 have significantly reduced cell motility. In
particular, the reduced motility of neuronal cell-derived
cell lines may be highly relevant to the neurodevelop-
mental disorder of FD patients.
Elongator and Its Association with the Coding
Region of Human Genes Are Altered
by the FD Mutation
The data above show that cells with reduced levels of
IKAP/hELP1 have decreased transcription of several
genes and that this has consequences for cell function.
However, precisely how these defects relate to the Elon-
gator complex and its cellular role was still not clear. Our
previous experiments performed in the analogous yeast
system showed that deletion of ELP1 leads to loss of
Elp3 and Elongator integrity (Petrakis et al., 2004). Ex-
tending from yeast to human cells, this result predicts
that the amount of functional Elongator should also be
altered in FD cells because of their decreased IKAP/
hELP1 production. Indeed, we found that the protein
level of the catalytic hELP3 subunit was significantly de-
creased in cells where lowered IKAP/hELP1 levels were
caused by either RNAi or the FD mutation (Figure 4A, left
and right, respectively). This indicates that, as expected
from the results in the yeast system, hElp3 levels are in-
deed affected by the removal of IKAP/hELP1. This sug-
gests that the lower levels of transcription observed in
cells depleted for IKAP/hELP1 are due to lower levels
of Elongator. To more directly investigate this possibil-
ity, we generated a hELP3 cellular loss of function model
by transfecting ELP3, or GFP, RNAi into fibroblasts. Un-
fortunately, although the ELP3 mRNA level was clearly
reduced (data not shown), ELP3 RNAi did not lead to
a very efficient depletion of this protein from cells (Fig-
ure 4B). Nevertheless, our experiments showed that gel-
solin and beclin-1, but not a-tubulin, expression was
consistently decreased in ELP3 RNAi fibroblasts, al-
though to a smaller extent than in IKAP/hELP1 RNAi
cells (Figure 4C). Therefore, these results suggest that
cell expression deficiencies of two Elongator subunits,
namely IKAP/hELP1 and ELP3, have similar conse-
quences for gene expression.
Elongator is detected in both the cytoplasm and nu-
cleus of human cells (see, for example, Hawkes et al.[2002], Kim et al. [2002], and Kouskouti and Talianidis
[2005]). We found that, not surprisingly, the protein is de-
pleted to a similar extent in both compartments in FD
cells (Figure S3). In theory, the effect of IKAP depletion
on gene expression could be either indirect or direct. If
the effect was direct, it would be expected that Elonga-
tor is present at the target genes and that its absence
has a specific effect on transcription at these genes. If,
in contrast, the effect was indirect, for example through
signaling from the cytoplasm, such effects would not be
expected. To address the possibility that the effect of re-
duced IKAP/hELP1 levels on transcription was direct,
standard ChIP technique in conjunction with quantita-
tive real-time PCR was used to detect the Elongator
complex at genes in normal and FD fibroblasts. The
use of FD fibroblasts served as an excellent control for
the specificity of the antibodies used, as lower levels
of IKAP would be expected to result in significantly de-
creased ChIP signals in these cells. Interestingly, we de-
tected IKAP/hElp1 not only in the coding region (and to
Figure 4. IKAP/hELP1 and ELP3 Depletion Have Similar Conse-
quences for Gene Expression
(A) Decreased hELP3 levels in human cells with low IKAP/hELP1
levels. Cell extracts from HT29 cells infected with the indicated
shRNA lentivirus (left panels) or from control or FD cells (right panels)
were subjected to Western blot analysis. The asterisk indicates
a nonspecific band obtained with the anti-ELP3 antibody in the
RNAi cells. This band serves as a loading control in this experiment.
(B) hELP3 depletion after IKAP/hELP1 and hELP3 RNAi in human
cells. Fibroblasts were transfected with GFP, IKAP/hELP1, or
hELP3 RNAi as indicated, and protein extracts were subjected to
anti-IKAP/hELP1, hELP3, and a-tubulin Western blot analysis.
(C) Gene expression of previously identified IKAP/hELP1-dependent
genes in GFP, IKAP/hELP1, and hELP3 RNAi fibroblasts. Real-time
PCR using primers to amplify the gelsolin, beclin-1, or a-tubulin tran-
scripts was performed by using total RNAs extracted from the GFP,
IKAP/hELP1, or ELP3 RNAi fibroblasts.
Error bars denote standard deviation.
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526Figure 5. Elongator Is Present on the Coding Region of Target and Nontarget Genes and Its Recruitment Is Affected by IKAP/hELP1 Depletion
(A) Schematic representation of the genes investigated by ChIP. Exons are depicted by boxes and transcription initiation sites (arrow with +1);
ORF start codons (ATG) and stop codons (STOP) are also indicated. The localization of primers used for ChIP analysis is illustrated by arrows
below. Numbers show the positions of these primers relative to the transcription initiation site.
(B) ChIP assays with an anti-IKAP/hELP1 antibody (Figure S7) were performed with normal (wt) or FD (FD) fibroblasts. Associated DNA was an-
alyzed by real-time PCR using primers derived from the promoter or the coding region of the indicated genes (gelsolin coding region primer, 62
kb; beclin-1, 8 kb; and a-tubulin, 6 kb). For ease of comparison, IKAP/hELP1 density in the coding region in normal fibroblasts was set to 100 and
the other values expressed relative to that. See the Experimental Procedures for details.
(C) ChIP assays with the Elongator antibodies indicated above the graphs were performed as in (A), using primers derived from the coding region
(62 kb) of the gelsolin gene. The fact that these antibodies coprecipitate less gelsolin DNA in FD cells indicates that recruitment of the whole
Elongator complex is reduced and that the antibodies are specific.
(D) ChIP assays with the Elongator antibodies indicated above the graphs were performed by using primers derived from the regions of the
beclin-1 gene indicated on the x axis. For ease of comparison, density at the promoter was set to 100 for each primer set and the other values
expressed relative to that.
Error bars denote standard deviation.a smaller extent the promoter) of the gelsolin and beclin-1
target genes, but also at the tubulin gene, whose ex-
pression is not affected by IKAP/hELP1 depletion
(Figure 5B). Experiments with fibroblasts derived from
FD patients showed that, as expected, the amount of
IKAP on the genes was indeed significantly decreased
in these cells (Figure 5B, compare wt and FD). Impor-
tantly, in agreement with the idea that IKAP is crucial
for Elongator function through targeting of the catalytic
hELP3 subunit, the recruitment of the hELP3 protein to
the coding region of the genes was indeed dramatically
affected by IKAP/hElp1 depletion. Likewise, recruitment
of other Elongator subunits, such as hELP4 and hELP5,
was decreased as well (Figure 5C, and Figure S4). These
data further indicate that recruitment of the whole Elon-
gator complex, not just the IKAP/hELP1 protein itself, is
affected by the mutation in FD cells.
To further characterize the association of Elongator
with active genes, we also investigated the relative den-
sity of IKAP/hELP1 and hELP3 across the beclin-1 gene
(see Figure 5A for the location of primer pairs across the
gene). The overall density profile of the proteins wasremarkably similar (Figure 5D), further supporting the
idea that the cellular level and function of the entire Elon-
gator complex is affected by decreasing the level of
IKAP/hELP1.
Decreased Elongator Levels Affect Histone H3
Acetylation in the Coding Region of Target Genes
To more precisely define the effects of IKAP/hELP1 mu-
tation on transcription, we now analyzed the density of
various histone modifications by ChIP analysis. In these
experiments, the FD cells were used as a tool to investi-
gate the effects of lower IKAP/Elongator levels. Interest-
ingly, histone H3-K9 acetylation, but not histone H4
acetylation, in the coding region of the gelsolin and be-
clin-1 genes was indeed reduced in cells with reduced
Elongator levels (Figures 6A and 6B, left and middle). A
similar reduction in acetylation was observed at histone
H3 K18 in the beclin-1 and gelsolin coding regions
(Figure 6C). It is important to note that reduced acetyla-
tion was not due to a loss of histone H3-DNA contacts in
the target genes, as histone acetylation levels were nor-
malized for histone content (using antibodies specific
Elongator Depletion Affects Transcript Elongation
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portantly, these effects were specific for the Elongator
target genes, as no significant change in histone modifi-
cation was observed at the a-tubulin control gene in FD
fibroblasts (Figures 6A, 6B, and 6C right). The lack of
effect of Elongator on histone acetylation at a-tubulin
is intriguing. Presumably, residual Elongator activity or
other HATs fulfill the requirements for histone acetyla-
tion at this gene, but not at the target genes in FD cells
(see Discussion).
Having established that Elongator affects the level of
H3 acetylation of target genes, we next more precisely
Figure 6. Low Levels of Elongator Result in Histone H3 Hypoacety-
lation through the Coding Region of Target Genes
(A) ChIP assays with an anti-histone H3K9ac-specific antibody were
performed with normal (wt) or FD (FD) fibroblasts. For ease of com-
parison, density in normal fibroblasts was set to 100 for each primer
set and the FD values expressed relative to that.
(B) As in (A) but using an anti-histone H4tetraAc-specific antibody.
(C) ChIP assays with an anti-histone H3K18ac-specific antibody
were performed with normal (wt) or FD (FD) fibroblasts. Primers
were derived from the indicated regions of the beclin-1, gelsolin,
and a-tubulin genes (see Figure 5A). For ease of comparison, density
in normal fibroblasts was set to 100 for each primer set and the FD
values expressed relative to that. Error bars denote standard devia-
tion. For a presentation of the data where the level of acetylation at
the promoter in wt cells was set to 100, see Figure S5. The reason for
the apparently normal level of acetylation observed at the very end
of the gelsolin gene in FD cells is unknown but might be due to the
next gene downstream being relatively near (w6 kb).defined the spatial distribution of histone H3 acetylation
across the genes. Interestingly, histone H3 acetylation
at the promoter and the beginning of the coding region
was more or less unaffected by the absence of IKAP/
Elongator. However, further into the open reading frame,
more dramatic decreases were observed (Figure 6C).
Again, histone acetylation in the coding region corre-
lated with the lower activity of IKAP/hELP1 target genes
in FD cells; it was lowered in the beclin-1 and gelsolin
genes but remained unchanged in the a-tubulin gene
(Figure 6C).
Previous results have shown that transcription is as-
sociated with increased acetylation of both histones
H3 and H4 (see, for example, Kouskouti and Talianidis
[2005]), but Elongator HAT activity primarily targets his-
tone H3 in vitro, and in vivo in yeast (Hawkes et al., 2002,
Kim et al., 2002; Wittschieben et al., 2000; Winkler et al.,
2002). The finding that histone H3, but not histone H4,
acetylation is decreased by IKAP/hELP1 depletion is
thus consistent with the idea that the observed change
in H3 acetylation levels is a direct effect of Elongator
depletion.
Progressively Decreased RNAPII Density
through Elongator Target Genes
We finally compared the density of RNAPII across the
tested genes. We surmised that if Elongator is indeed in-
volved in transcriptional elongation, then the density of
RNAPII might be expected to be relatively lower in the
30 end of the gene than at the promoter upon IKAP deple-
tion. Remarkably, RNAPII density was indeed progres-
sively decreased in FD cells across both the gelsolin
and beclin-1 genes (Figure 7), with an RNAPII density
similar to wild-type observed at the promoter, but only
w30% density observed at the end of the gene. In con-
trast, the RNAPII density at the a-tubulin control gene
was largely unaffected by the decrease in IKAP/Elonga-
tor levels, as expected (Figure 7). Together, these data
indicate that Elongator affects transcript elongation,
but not recruitment of RNAPII to the promoter, of genes
whose expression is affected by decreased IKAP/hELP1
levels. The very specific effects of IKAP depletion on his-
tone acetylation and RNAPII density across target genes
are consistent with a direct effect of Elongator on tran-
scriptional elongation rather than with an indirect effect
caused by its role in the cytoplasm.
Discussion
The data presented here provide several key insights
into Elongator function. First, they demonstrate a role
for Elongator in histone H3 acetylation and transcrip-
tional elongation of human genes. Second, they indicate
that the mutation carried by individuals suffering from
FD causes abrogation of Elongator function, not just of
IKAP/hELP1 expression. Third, normal levels of Elonga-
tor are important for normal expression of several hu-
man genes, including some implicated in cell motility.
Indeed, HeLa and neuronal-derived IKAP/hELP1 RNAi
cells, as well as FD fibroblasts, exhibit defects in cell
motility in vitro. Cell motility is crucial for the normal
development and maintenance of the nervous system,
so our data also point to molecular defects that may
underlie FD.
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Integrity and Function
In yeast, the Elp1 protein assembles the Elongator com-
plex, which also includes the histone acetyltransferase
Elp3 and four additional subunits. The crucial impor-
tance of Elp1 for Elongator integrity is underscored by
the fact that deletion of ELP1 in yeast results in the cat-
alytic Elp3 subunit becoming undetectable (Petrakis
et al., 2004). Here, we show that IKAP/hELP1 depletion
also results in lower hELP3 levels in human cells. More-
over, hELP3 depletion through RNAi also results in de-
creased mRNA levels of the tested IKAP/hELP1-depen-
dent genes, supporting the idea that the uncovered
effects are due to defects in the function of the Elongator
complex. However, although we consider it unlikely,
it cannot be ruled out that hELP1/IKAP also has roles
distinct from that in the Elongator complex.
It is essential to emphasize that although RNAi and the
FD mutation affect IKAP/hELP1 levels, there are still sig-
nificant levels of the protein in these cells. We believe
this residual amount may be important for transcription
of a larger number of genes, as well as for cellular viabil-
ity. Indeed, the ELP1/IKBKAP gene, as well as the ELP3
gene, is essential in Drosophila melanogaster, and the
mutants die with a remarkably similar terminal pheno-
type (Jane Walker and J.Q.S., unpublished data; James
Gusella, personal communication).
Figure 7. Low Levels of Elongator Result in Progressively Lower
Density of RNAPII through the Coding Region of Target Genes
ChIP assays with an anti-RNAPII antibody (4H8) were performed
with normal (wt) or FD (FD) fibroblasts. Primers were derived from
the indicated regions of the gelsolin, beclin-1, and a-tubulin genes
(see Figure 5A for localization of primers). For ease of comparison,
density in normal fibroblasts was set to 100 for each primer set
and the FD values expressed relative to that. Error bars denote stan-
dard deviation. For a presentation of the data where the level of acet-
ylation at the promoter in normal cells was set to 100, see Figure S6.It is worth pointing out that we detected Elongator not
only on genes whose expression was affected by de-
creased IKAP/hELP1 levels but also on the unaffected
a-tubulin gene. Other researchers have previously re-
ported that Elongator was detected on three genes ex-
amined by ChIP but that factors such as FACT, CBP,
PCAF, and SNF2H were only found at one or two of
the genes studied (Kouskouti and Talianidis, 2005).
Elongator was also detected at the estrogen-inducible
pS2 gene (Metivier et al., 2003). Elongator is thus present
at several genes, yet our expression data suggest that
only relatively few are affected by IKAP/Elongator deple-
tion. Interestingly, this finding fits well with recent data
on other chromatin modifying factors. For example, his-
tone acetyltransferases such as Gcn5 and Esa1 are both
generally recruited to promoters of active genes in yeast
yet only affect the expression of a small percentage of
these genes (Robert et al. [2004] and references therein).
So, although the mechanism underlying the lack of ef-
fects of Elongator depletion at, for example, the a-tubu-
lin gene remains unknown, the finding is not unex-
pected. Possibly, histone acetylation may simply not
be essential for the expression of this and other genes,
or more likely, residual Elongator activity and/or other
HATs/chromatin remodelers fulfill the requirements.
Elongator Functions in Transcript Elongation
in Human Cells
The data presented here provide evidence in support of
the previously proposed model for Elongator function
(Otero et al., 1999; Wittschieben et al., 1999). According
to this model, Elongator acetylates histones during tran-
scription as a component of an elongating RNAPII holo-
enzyme. Our ChIP experiments thus clearly show that
Elongator is present in the coding region of genes and
that histone H3 acetylation is significantly reduced in
the coding region, but not at the promoter, of affected
genes in its absence. Moreover, RNAPII density is pro-
gressively lowered through the coding region of target
genes. Elongator depletion leaves RNAPII recruitment
to the promoter largely unaffected, and RNAPII density
in the first few hundred to several thousand nucleotides
of the open reading frame is also normal. This supports
the idea that Elongator assists RNAPII during transcript
elongation through chromatin as the polymerase moves
further and further away from a promoter and the activity
sphere of HATs such as PCAF and p300/CBP (Kouskouti
and Talianidis, 2005), whose activity are likely overlap-
ping with that of Elongator in the 50 end of genes. To
our knowledge, these results represent the first demon-
stration of a role specifically in the transcript elongation
phase for an elongation factor in human cells.
Because data from ChIP experiments can only show
a correlation between the presence of a factor and ef-
fects at sites of action, our ChIP data from human cells
do not in themselves prove that Elongator acetylates
histones during transcriptional elongation. However, it
is of importance not to view these new results out of
context. First, recent results have shown that both his-
tone H3 and H4 acetylation is measurably increased in
the coding region of several human genes as a conse-
quence of active transcription (Kouskouti and Talianidis,
2005). We have shown that Elongator is primarily a his-
tone H3 acetyltransferase in vitro (Winkler et al., 2002;
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therefore striking that histone H3, but not H4 acetylation,
was decreased by Elongator depletion in FD cells. Sec-
ond, previous data from yeast showed that mutations in
Elongator are synthetic lethal with mutations in the N-
terminal tail of histone H4, suggesting that Elongator
function is required for normal histone H3 function
in vivo (in the absence of the H4 tail, correct function
of the H3 tail is essential) (Wittschieben et al. [2000]
and references therein). Third, yeast cells lacking both
ELP3 and the gene encoding another histone H3 acetyl-
transferase, GCN5, have severe growth defects, and
these growth defects can be suppressed specifically
by concurrently deleting the histone deacetylases
HDA1 and HOS2 (Wittschieben et al., 2000). Although
the data reported here support the idea that human
Elongator targets both lysine H3 K9 and H3 K18
in vivo, this does not rule out the possibility that lysine
H3 K14, which is a primary target site of purified yeast
Elongator in vitro, is targeted in human cells as well
(see Kristjuhan et al. [2002] for a discussion of the site
specificity of HATs). Taken together with the data from
the yeast model, our results using human cells strongly
point to a function for Elongator in histone acetylation
during transcript elongation.
IKAP/Elongator DepletionResults in Downregulation
of Genes Required for Normal Cell Motility
Several models for the function of IKAP/hELP1 and
Elongator have been proposed. Cohen et al. (1998) and
Holmberg et al. (2002) suggested that IKAP/hELP1
might be involved in cytoplasmic signaling in the NF-kB
and JNK pathways, respectively. Our data, and those
of others (Krappmann et al., 2000), failed to support an
involvement of IKAP/hELP1 in these cytoplasmic signal
transduction pathways. The name IKAP is therefore in all
likelihood a misnomer, and we suggest that the protein
should be designated human ELP1 (hELP1) instead.
In yeast, Elongator has been implicated in cellular re-
actions as diverse as tRNA modification (Huang et al.,
2005) and exocytosis (Rahl et al., 2005). Indeed, Rahl
et al. proposed that FD is caused by an exocytosis de-
fect. These authors showed that a defect in yeast exocy-
tosis resulting from sec2-52 mutation (which creates
a premature stop codon after the first 374 residues of
the essential Sec2 protein) could be overcome by Elon-
gator gene deletion. Unfortunately, the data in support
of this unusual suppression effect being direct were un-
persuasive. For example, an interaction between full-
length Elp1 and Sec2 could only be demonstrated by
the use of a potent protein-protein crosslinker. In our
experience, the use of such crosslinkers in crude ex-
tracts requires several specificity controls, which were
not provided. Interestingly, the reported involvement
of Elongator in tRNA modification (translation fidelity)
raises the possibility that the sec2-52 suppression is
caused by increased stop codon readthrough in elp
strains, as elp mutation can affect the recognition of
ochre codons (Huang et al., 2005). elp mutation might
obviously also affect expression of exocytosis genes
via Elongator’s role in transcription. It thus remains un-
clear if the effect of Elongator on exocytosis is direct
and if the yeast exocytosis data are relevant for FD.
In any case, it remains a possibility that translationalimprecision might contribute to FD (and to the defects
resulting from Elongator disruption in yeast).
In general, the most plausible explanation for the pre-
viously reported cellular localization data seems to be
that Elongator plays roles in distinct cellular processes,
in distinct cellular compartments, as previously pro-
posed (Gilbert et al., 2004). The complex nature of Elon-
gator function and its relationship with basic cellular
functions are further underscored by the data presented
here. We thus demonstrated that Elongator plays a key
role in transcription of several genes that regulate the
actin cytoskeleton and cell motility/migration and that
decreases in Elongator levels indeed result in cell migra-
tion defects in four different tested cell types, including
neuronal-derived cells. It is worth noting that although
the data presented here strongly argue that the cell mi-
gration defect is a consequence of lowered expression
of genes required for this process, we cannot rule out
the possibility that Elongator also plays a more direct
role in cell motility, for example via its cytoplasmic local-
ization.
Impaired Cell Motility May Underlie FD
FD is a neurodevelopmental and neurodegenerative ge-
netic disorder with severe pathological consequences
(reviewed by Slaugenhaupt and Gusella [2002] and Axel-
rod [2004]). IKAP/hELP1 mutation affects the develop-
ment and maintenance of neurons, resulting in neuro-
pathological and clinical progression. To appreciate
the potential importance of the connection between im-
paired cell motility observed in cells with decreased
levels of IKAP/hELP1 protein and the neuropathology
of FD patients, it is important to realize that the actin cy-
toskeleton and cell motility play crucial roles in nerve cell
growth cone motility, axon outgrowth, and guidance.
Moreover, cell motility and the actin cytoskeleton also
play central roles at the level of neuritogenesis (the
sprouting of neurites, which will later become axons
and dendrites) and in the migration of neurons to their fi-
nal destination in the brain (reviewed by Dent and Gertler
[2003] and da Silva and Dotti [2002]). Our data thus sug-
gest an intriguing model to explain FD at the molecular
level: the mutation in the gene encoding IKAP/hELP1 re-
sults in a tissue (brain)-specific decrease in the ability of
cells to migrate, which in turn leads to neuro-develop-
mental abnormalities and the neuropathology of FD pa-
tients. Obviously, other genes that are downregulated in
cells upon Elongator depletion may contribute to the
disease as well.
FD is a devastating disease, and in spite of significant
advances in prognosis due to better supportive treat-
ment, only about 40% of patients are more than 20 years
old (Axelrod, 2004). The data presented here will hope-
fully provide important clues to future treatment of the
disorder.
Experimental Procedures
Cell Culture and Reagents
HeLa and 293T cells were maintained in DMEM supplemented with
10% fetal bovine serum (Life Technologies) and antibiotics, whereas
fibroblasts (Slaugenhaupt et al., 2001) were cultured in DMEM sup-
plemented with 20% FBS, 1% antibiotics, and 1% L-glutamine.
HT29 cells were cultured in EMEM supplemented with 10% NEAA,
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530antibiotics, and L-glutamine. SK-N-BE and U373 cells were cultured
in RPMI supplemented with 10% FCS and antibiotics.
Monoclonal anti-IKAP for Western blot analysis was purchased
from BD Biosciences Pharmingen. Anti-IKAP antisera for ChIP
analysis were raised in rabbits against an IKAP peptide. Anti-paxillin
and -Rac antibodies were from Upstate Biotechnology; anti-p38,
-phospho p38, -Akt, and -phospho Akt antibodies from Cell Signal-
ing; anti-Erk1, -phospho Erk1, -JNK, -IkBa, -a-tubulin, and -calreticu-
lin antibodies from Santa Cruz Biotechnologies; rabbit polyclonal
anti-acetyl H3 K9, anti-acetyl H3 K18, and anti-acetyl H4 antibody,
as well as 4H8 antibody used to precipitate RNAPII, were from Up-
state Biotechnology; and rabbit polyclonal anti-H3 (C-terminus anti-
body) was from Abcam. Antibodies directed against Elp3, Elp4, and
Elp5 have been described previously (Petrakis et al. [2004] and refer-
ences therein). GST-c-Jun was from BIOMOL.
RNAi Transfection and Lentiviral Cell Infection
RNAi oligos were synthesized by Dharmacon Research (sequences
available upon request) and were transfected into HeLa or HT29
cells by using the oligofectamine reagent (Invitrogen) or by calcium
phosphate in fibroblasts. Cells were lyzed 48 hr posttransfection,
and anti-IKAP/hELP1 and -ELP3 Western blots performed. The
pLL3.7 lentivirus and instructions on its use was kindly provided
by Dr. L. van Parijs (MIT, Boston, MA) (Rubinson et al., 2003). Details
are available upon request.
Total RNA Extraction, Microarray Analysis, and Real-Time PCRs
Total RNA extraction from RNAi cells was carried out by using the
RNeasy Mini kit (Qiagen). Double-stranded cDNAs were generated
by using the superscript II RT kit (Invitrogen). Subsequently, bio-
tin-labeled cRNA was generated with the Bioarray High Yield RNA
Transcript Labeling Kit (Enzo Life Science). cRNAs were hybridized
with the Human Genome U133A array, which harbors >22,000 probe
sets (Affymetrix). Data were processed with GeneChip Operating
Software (Affymetrix). Quantitative real-time PCR was performed
with TaqMan 7000 SDS (Applied Biosystems), using SybrGreen
detection. Primers sequences are available upon request.
Wound-Healing, Chemotaxis Assays, and Collagen
Matrix Contraction
For wound-healing assays, HeLa, SK-N-BE, or U373 cells stably in-
fected with lentivirus-delivering RNAi, or wild-type and FD fibro-
blasts, were grown until confluence. SK-N-BE and U373 cells were
plated on fibronectin-coated plates. Mitomycin C (1 mg/ml) was
added to the culture media 2 hr before ‘‘wounding’’ to inhibit cell pro-
liferation. Wound areas were generated by scraping with a pipette
tip, and disrupted monolayers were randomly photographed in mul-
tiple fields (T = 0). Cell migration/wound healing was similarly as-
sessed over the following hours.
For chemotaxis assays using a Boyden chamber (Riedy et al.,
1999), HeLa or SK-N-BE and U373 cells were added to serum-free
medium in 24-well multiwell plates (Corning Incorporated). The lower
compartment was filled with medium supplemented with 10% FBS.
Cells were incubated at 37ºC. Cells on the upper surface were re-
moved, and membranes were fixed in ethanol at220ºC and stained
with Giemsa 4%. Migrated cells were randomly photographed
(10 fields/insert) and counted.
Collagen gel contraction experiments were performed as de-
scribed (Lambert et al., 1992), using 1 mg collagen lattice.
Kinase Assays
Anti-JNK immunoprecipitates were used in kinase assays per-
formed at 30ºC for 30 min with 1 mg of purified GST-c-Jun fusion pro-
tein and 10 mCi of [g32P] ATP in 20 ml kinase buffer (20 mM HEPES
[pH 7.4], 10 mM MgCl2, 25 mM b-glycerophosphate, 50 mM
Na3VO4, and 50 mM DTT). Phosphorylated c-Jun proteins were de-
tected by autoradiography after 10% SDS-PAGE.
ChIP Assays
ChIP assays were performed by standard techniques (see, for exam-
ple, Kouskouti and Talianidis [2005]). Extracts were precleared by 1h
incubation with protein A or G/Herring sperm DNA, and immunopre-
cipitation was performed by incubating overnight at 4ºC with the rel-
evant antibody, using HA antibody or preimmune serum as negativecontrols, and then 1 hr with protein A or G/Herring sperm DNA. Pro-
tein-DNA complexes were washed as per standard ChIP tech-
niques. After elution, proteinase K treatment, and reversal of cross-
links, DNA fragments were analyzed by real-time PCR with SYBr
Green detection. Input DNA was analyzed simultaneously and
used as normalization. For normalization of the RNAPII ChIPs, the
signal obtained from a noncoding region (downstream from the al-
bumin gene [see Kouskouti and Talianidis (2005)]) was used to com-
pensate for possible fluctuations arising during handling. For the
histone-related ChIPs, acetyl-histone-specific ChIP values were
normalized according to the total H3 signal (as detected with the C
terminus-specific anti-histone H3 antibody).
Supplemental Data
Supplemental Data include Supplemental References and seven fig-
ures and can be found with this article online at http://www.
molecule.org/cgi/content/full/22/4/521/DC1/.
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